Search
for

    Sort by

    Research 30 of 46

    1. Case of alemtuzumab-related alopecia areata management in MS Neurology Neuroimmunology & Neuroinflammation · 2018 · 10 citations
    2. Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients 2021 · 3 citations
    3. 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature 2024
    4. Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D? Medical research archives · 2022
    5. Mycosis Fungoides in Elderly Adults—A Diagnostic Challenge Journal of the American Geriatrics Society · 2014 · 1 citations
    6. Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol Open Science Framework · 2026
    7. BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena? 2023
    8. The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis Journal of Neuro-Ophthalmology · 2018 · 4 citations
    9. Index 2013
    10. Mechanisms regulating skin immunity and inflammation Nature Reviews Immunology · 2014 · 610 citations
    11. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    12. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    13. Current management strategies for cutaneous T-cell lymphoma Clinics in Dermatology · 2004 · 39 citations
    14. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    15. Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? Neurology and Therapy · 2018 · 5 citations
    16. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    17. Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia Clinical and Experimental Dermatology · 2015 · 1 citations
    18. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    19. Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance Frontiers in Medicine · 2026
    20. Real-world pharmacovigilance insights into drug-induced risk of alopecia Frontiers in Pharmacology · 2025
    21. Folliculotropic mycosis fungoides Acta Haematologica Polonica · 2021
    22. Comparison of allogeneic stem cell transplant conditioning regimens in AML, MDS and CLL General internal medicine and clinical innovations · 2018
    23. Hair loss due to treatment of multiple sclerosis Neurologie pro praxi · 2017
    24. Benign Cutaneous Eruptions After Transplantation Springer eBooks · 2017
    25. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis Pediatric blood & cancer · 2015 · 26 citations
    26. Three Cases of Alopecia Following Clinical Islet Transplantation American journal of transplantation · 2010 · 11 citations
    27. Drug-induced alopecia areata: A systematic review Journal of the American Academy of Dermatology · 2023 · 3 citations
    28. Alopecia areata in solid organ transplant recipients: A retrospective analysis JAAD International · 2025
    29. FRI549 The See-Saw Theory - Hypothyroidism Due To Hashimoto's Thyroiditis Followed By Hyperthyroidism Due To Graves' Disease Journal of the Endocrine Society · 2023
    30. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations